Fast Company has an interview with 23andMe co-founders, Linda Avey and Anne Wojcicki. Mostly they talk about using genetic testing information to form social networks and to give people the opportunity to connect on different, possibly deeper, levels as per health-related concerns. "Part of the thing that really motivated me in getting into this was adverse events," Avey says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.